col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


116 Results       Page 1

 [1] 
Elsevier: Cell Host & Microbe
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―23 The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome Qi Su, Raphaela I. Lau, Qin Liu, Moses K.T. Li, Joyce Wing Yan Mak, Wenqi Lu, et al. (+10)
2 [GO] 2024―Jan―26 Virological characteristics of the SARS-CoV-2 BA.2.86 variant Tomokazu Tamura, Keita Mizuma, Hesham Nasser, Sayaka Deguchi, Miguel Padilla-Blanco, Yoshitaka Oda, et al. (+30)
3 [GO] 2024―Jan―10 Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant Thomas R. Müller, Yu Gao, Jinghua Wu, Oriana Ribeiro, Puran Chen, Peter Bergman, et al. (+18)
4 [GO] 2024―Jan―10 Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant Rofhiwa Nesamari, Millicent A. Omondi, Richard Baguma, Maxine A. Höft, Amkele Ngomti, Anathi A. Nkayi, et al. (+14)
5 [GO] 2023―Nov―28 Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster Xun Wang, Shujun Jiang, Wentai Ma, Xiangnan Li, Kaifeng Wei, Faren Xie, et al. (+18)
6 [GO] 2023―Nov―08 Cross-regulation of antibody responses against the SARS-CoV-2 Spike protein and commensal microbiota via molecular mimicry Marina Bondareva, Lisa Budzinski, Pawel Durek, Mario Witkowski, Stefan Angermair, Justus Ninnemann, et al. (+34)
7 [GO] 2023―Sep―21 Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis Thomas Kehrer, Anastasija Cupic, Chengjin Ye, Soner Yildiz, Mehdi Bouhaddou, Nicholas A. Crossland, et al. (+34)
8 [GO] 2023―Sep―13 Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2 Minghua Li
9 [GO] 2023―Jul―31 Rational design of a booster vaccine against COVID-19 based on antigenic distance Ye-Fan Hu, Terrence Tsz-Tai Yuen, Hua-Rui Gong, Bingjie Hu, Jing-Chu Hu, Xuan-Sheng Lin, et al. (+12)
10 [GO] 2023―Jul―03 The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage Xiaoyuan Lin, Zhou Sha, Jakob Trimpert, Dusan Kunec, Chen Jiang, Yan Xiong, et al. (+4)
11 [GO] 2023―Jun―16 Gut microbiota, malnutrition, and immunity: COVID-19’s confounding triad Anna Creus-Cuadros, M. Mahebali Tabusi, Valeria Carpio-Arias, B. Brett Finlay
12 [GO] 2023―Jun―16 COVID-19 as a catalyst for vaccine manufacturing: A South African experience Penny L. Moore, Glenda Gray
13 [GO] 2023―Jun―16 The coronavirus recombination pathway Heather L. Wells, Cassandra M. Bonavita, Isamara Navarrete-Macias, Blake Vilchez, Angela L. Rasmussen, Simon J. Anthony
14 [GO] 2023―Jun―16 Antiviral strategies for epidemic and pandemic preparedness Dirk Jochmans, Manon Laporte, Johan Neyts
15 [GO] 2023―Jun―16 Lessons learned for pandemic preparedness: A collaborative network is imperative Jacqueline M. Fabius, Nevan J. Krogan
16 [GO] 2023―Jun―16 Pregnancy-associated morbidity and mortality during pandemics: Looking to the past in order to prepare for the future Allyson Caldwell, Carolyn B. Coyne
17 [GO] 2023―Jun―16 The role of trained immunity in COVID-19: Lessons for the next pandemic Mihai G. Netea, Athanasios Ziogas, Christine Stabell Benn, Evangelos J. Giamarellos-Bourboulis, Leo A.B. Joosten, Moshe Arditi, et al. (+5)
18 [GO] 2023―Feb―08 Stoking inflammasome fires in the COVID-19 neighborhood Larisa I. Labzin, Kate Schroder
19 [GO] 2023―Feb―08 Versatile use of bat ACE2 for cellular entry by MERS-CoV-like viruses Kaushal Baid, Arinjay Banerjee
20 [GO] 2023―Jan―11 Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
21 [GO] 2022―Dec―14 SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19 Alba Grifoni, John Sidney, Randi Vita, Bjoern Peters, Shane Crotty, Daniela Weiskopf, Alessandro Sette
22 [GO] 2022―Dec―09 An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2 Katherine C. Barnett, Yuying Xie, Takanori Asakura, Dingka Song, Kaixin Liang, Sharon A. Taft-Benz, et al. (+12)
23 [GO] 2022―Nov―22 Enhanced Neutralization Resistance of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2 Panke Qu, John P. Evans, Julia Faraone, Yi-Min Zheng, Claire Carlin, Mirela Anghelina, et al. (+10)
24 [GO] 2022―Oct―18 Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine Yangtao Wu, Shaojuan Wang, Yali Zhang, Lunzhi Yuan, Qingbing Zheng, Min Wei, et al. (+37)
25 [GO] 2022―Oct―18 Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant Akatsuki Saito, Tomokazu Tamura, Jiri Zahradnik, Sayaka Deguchi, Koshiro Tabata, Yuki Anraku, et al. (+42)
26 [GO] 2022―Sep―28 Evasion of Neutralizing Antibody Responses by the SARS-CoV-2 BA.2.75 Variant Panke Qu, John P. Evans, Yi-Min Zheng, Claire Carlin, Linda J. Saif, Eugene M. Oltz, et al. (+3)
27 [GO] 2022―Sep―06 Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75 Qian Wang, Sho Iketani, Zhiteng Li, Yicheng Guo, Andre Yanchen Yeh, Michael Liu, et al. (+5)
28 [GO] 2022―Aug―11 Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites Sho Iketani, Seo Jung Hong, Jenny Sheng, Farideh Bahari, Bruce Culbertson, Fereshteh Fallah Atanaki, et al. (+9)
29 [GO] 2022―Aug―04 Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein Kamyab Javanmardi, Thomas H. Segall-Shapiro, Chia-Wei Chou, Daniel R. Boutz, Randall J. Olsen, Xuping Xie, et al. (+9)
30 [GO] 2022―Jul―20 Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic Esther Dawen Yu, Tara M. Narowski, Eric Wang, Emily Garrigan, Jose Mateus, April Frazier, et al. (+5)
31 [GO] 2022―Jul―18 Determinants of Spike Infectivity, Processing and Neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2 Chiara Pastorio, Fabian Zech, Sabrina Noettger, Christoph Jung, Timo Jacob, Theo Sanderson, et al. (+2)
32 [GO] 2022―Jul―07 SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns Henning Gruell, Kanika Vanshylla, Michael Korenkov, Pinkus Tober-Lau, Matthias Zehner, Friederike Münn, et al. (+7)
33 [GO] 2022―Jun―20 Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America Bernardo Gutierrez, Hugo G. Castelán Sánchez, Darlan da Silva Candido, Ben Jackson, Shay Fleishon, Renaud Houzet, et al. (+6)
34 [GO] 2022―May―08 Antibody Evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 and BA.3 Sub-lineages Jingwen Ai, Xun Wang, Xinyi He, Xiaoyu Zhao, Yi Zhang, Yuchao Jiang, et al. (+10)
35 [GO] 2022―May―06 SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies Prerna Arora, Lu Zhang, Nadine Krüger, Cheila Rocha, Anzhalika Sidarovich, Sebastian Schulz, et al. (+9)
36 [GO] 2022―Apr―25 Neutralization of SARS-CoV-2 Omicron Sub-lineages BA.1, BA.1.1, and BA.2 John P. Evans, Cong Zeng, Panke Qu, Julia Faraone, Yi-Min Zheng, Claire Carlin, et al. (+10)
37 [GO] 2022―Apr―13 Interferons in coronavirus pathogenesis: The good, the bad, and the ugly Rudragouda Channappanavar
38 [GO] 2022―Mar―29 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved Spike epitope Xiaofei Wang, Xiangyu Chen, Jiaxing Tan, Shuai Yue, Runhong Zhou, Yan Xu, et al. (+7)
39 [GO] 2022―Mar―25 SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated individuals Simone I. Richardson, Vimbai Sharon Madzorera, Holly Spencer, Nelia P. Manamela, Mieke A. van der Mescht, Bronwen E. Lambson, et al. (+19)
40 [GO] 2022―Mar―22 Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2 Kathryn E. Kistler, John Huddleston, Trevor Bedford
41 [GO] 2022―Feb―18 Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2 Hongjie Xia, Jing Zou, Chaitanya Kurhade, Hui Cai, Qi Yang, Mark Cutler, et al. (+6)
42 [GO] 2022―Feb―08 Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status. Esther Dawen Yu, Eric Wang, Emily Garrigan, Benjamin Goodwin, Aaron Sutherland, Alison Tarke, et al. (+14)
43 [GO] 2022―Jan―25 Persistent B-cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections. Sara Terreri, Eva Piano Mortari, Maria Rosaria Vinci, Cristina Russo, Claudia Alteri, Christian Albano, et al. (+24)
44 [GO] 2022―Jan―21 Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission Alba Escalera, Ana S. Gonzalez-Reiche, Sadaf Aslam, Ignacio Mena, Manon Laporte, Rebecca L. Pearl, et al. (+23)
45 [GO] 2022―Jan―14 SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape Sandile Cele, Farina Karim, Gila Lustig, James Emmanuel San, Tandile Hermanus, Houriiyah Tegally, et al. (+22)
46 [GO] 2021―Dec―18 Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers Kanika Vanshylla, Chengcheng Fan, Marie Wunsch, Nareshkumar Poopalasingam, Matthijs Meijers, Christoph Kreer, et al. (+21)
47 [GO] 2021―Dec―07 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response Chun-Yang Lin, Joshua Wolf, David C. Brice, Yilun Sun, Macauley Locke, Sean Cherry, et al. (+16)
48 [GO] 2021―Dec―03 Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, Dani Vézina, Romain Gasser, Lauriane Nault, et al. (+31)
49 [GO] 2021―Nov―27 The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants Chang Liu, Daming Zhou, Rungtiwa Nutalai, Helen M.E. Duyvesteyn, Aekkachai Tuekprakhon, Helen M. Ginn, et al. (+25)
50 [GO] 2021―Nov―13 Nucleocapsid mutations R203K/G204R increase the infectivity, fitness and virulence of SARS-CoV-2 Haibo Wu, Na Xing, Kaiwen Meng, Beibei Fu, Weiwei Xue, Pan Dong, et al. (+8)
51 [GO] 2021―Nov―12 Direct Comparison of Antibody Responses to Four SARS-CoV-2 Vaccines in Mongolia Naranjargal J. Dashdorj, Oliver F. Wirz, Katharina Röltgen, Emily Haraguchi, Anthony S. Buzzanco, Mamdouh Sibai, et al. (+34)
52 [GO] 2021―Oct―14 Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner Roanne Keeton, Simone I. Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B. Tincho, Ntombi Benede, et al. (+29)
53 [GO] 2021―Aug―07 An AAV-based, room-temperature stable, single dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates Nerea Zabaleta, Wenlong Dai, Urja Bhatt, Cécile Hérate, Pauline Maisonnasse, Jessica A. Chichester, et al. (+48)
54 [GO] 2021―Jul―14 An aberrant inflammatory response in severe COVID-19 Miriam Merad, Aruna Subramanian, Taia T. Wang
55 [GO] 2021―Jul―14 Global COVID-19 vaccine inequity: The scope, the impact, and the challenges Archana Asundi, Colin O’Leary, Nahid Bhadelia
56 [GO] 2021―Jul―14 Children and SARS-CoV-2 Dusan Bogunovic, Miriam Merad
57 [GO] 2021―Jul―14 Virus hunters: Discovering the evolutionary origins of SARS-CoV-2 Arinjay Banerjee
58 [GO] 2021―Jul―14 SnapShot: SARS-CoV-2 antibodies David C. Montefiori, Priyamvada Acharya
59 [GO] 2021―Jul―14 The success of SARS-CoV-2 vaccines and challenges ahead Kanta Subbarao
60 [GO] 2021―Jul―14 The devil in the details: Herd immunity and pandemic response Beau Schaeffer, Bradford Taylor, Mary Bushman, William P. Hanage
61 [GO] 2021―Jun―24 Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease James Brett Case, Rita E. Chen, Longxing Cao, Baoling Ying, Emma S. Winkler, Max Johnson, et al. (+12)
62 [GO] 2021―Jun―17 Antibody and B cell responses to SARS-CoV-2 infection and vaccination Katharina Röltgen, Scott D. Boyd
63 [GO] 2021―Jun―15 SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity Chihiro Motozono, Mako Toyoda, Jiri Zahradnik, Akatsuki Saito, Hesham Nasser, Toong Seng Tan, et al. (+21)
64 [GO] 2021―Jun―04 A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T-cell responses Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, Shang Yu Gong, Romain Gasser, Guillaume Beaudoin-Bussières, et al. (+29)
65 [GO] 2021―Jun―03 HIV-1 and SARS-CoV-2: Patterns in the Evolution of Two Pandemic Pathogens Will Fischer, Elena E. Giorgi, Srirupa Chakraborty, Kien Nguyen, Tanmoy Bhattarcharya, James Theiler, et al. (+9)
66 [GO] 2021―May―21 SARS-CoV-2 Human T cell Epitopes: adaptive immune response against COVID-19. Alba Grifoni, John Sidney, Randi Vita, Bjoern Peters, Shane Crotty, Daniela Weiskopf, Alessandro Sette
67 [GO] 2021―May―17 Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19 Shea A. Lowery, Alan Sariol, Stanley Perlman
68 [GO] 2021―May―03 Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans Kanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, Felix Dewald, Philipp Schommers, Lutz Gieselmann, et al. (+20)
69 [GO] 2021―Apr―19 Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Maple Wang, Jian Yu, Gabriele Cerutti, et al. (+5)
70 [GO] 2021―Apr―16 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection Hejun Liu, Meng Yuan, Deli Huang, Sandhya Bangaru, Fangzhu Zhao, Chang-Chun D. Lee, et al. (+14)
71 [GO] 2021―Mar―21 Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, Lilin Lai, Meredith E. Davis-Gardner, William H. Hudson, et al. (+28)
72 [GO] 2021―Mar―14 Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite Gabriele Cerutti, Yicheng Guo, Tongqing Zhou, Jason Gorman, Myungjin Lee, Micah Rapp, et al. (+17)
73 [GO] 2021―Mar―11 The great escape? SARS-CoV-2 variants evading neutralizing responses Jérémie Prévost, Andrés Finzi
74 [GO] 2021―Mar―07 SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, William Fischer, James Theiler, et al. (+11)
75 [GO] 2021―Feb―25 Robust SARS-CoV-2 Infection in Nasal Turbinates after Treatment with Systemic Neutralizing Antibodies Dongyan Zhou, Jasper Fuk-Woo Chan, Biao Zhou, Runhong Zhou, Shuang Li, Sisi Shan, et al. (+22)
76 [GO] 2021―Feb―24 One Year of SARS-CoV-2 Evolution Aiping Wu, Lulan Wang, Hang-Yu Zhou, Cheng-Yang Ji, Shang Zhou Xia, Yang Cao, et al. (+5)
77 [GO] 2021―Feb―09 Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies Allison J. Greaney, Andrea N. Loes, Katharine H.D. Crawford, Tyler N. Starr, Keara D. Malone, Helen Y. Chu, Jesse D. Bloom
78 [GO] 2021―Jan―29 Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response Jing-wen Lin, Chao Tang, Han-cheng Wei, Baowen Du, Chuan Chen, Minjin Wang, et al. (+68)
79 [GO] 2021―Jan―27 Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, Paul W. Rothlauf, Rita E. Chen, Spencer Stumpf, et al. (+10)
80 [GO] 2021―Jan―14 Zooanthroponotic potential of SARS-CoV-2 and implications of re-introduction into human population Arinjay Banerjee, Karen Mossman, Michelle L. Baker
81 [GO] 2020―Dec―26 Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19 Qirui Guo, Yingchi Zhao, Junhong Li, Jiangning Liu, Xiuhong Yang, Xuefei Guo, et al. (+17)
82 [GO] 2020―Dec―17 Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors H.-Heinrich Hoffmann, Francisco J. Sánchez-Rivera, William M. Schneider, Joseph M. Luna, Yadira M. Soto-Feliciano, Alison W. Ashbrook, et al. (+13)
83 [GO] 2020―Dec―17 Intranasal Vaccination with a Lentiviral Vector Protects against SARS-CoV-2 in Preclinical Animal Models Min-Wen Ku, Maryline Bourgine, Pierre Authié, Jodie Lopez, Kirill Nemirov, Fanny Moncoq, et al. (+17)
84 [GO] 2020―Dec―09 FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein Vitor Hugo B. Serrão, Jeffrey E. Lee
85 [GO] 2020―Nov―20 Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, et al. (+14)
86 [GO] 2020―Nov―17 Integrative imaging reveals SARS-CoV-2 induced reshaping of subcellular morphologies Mirko Cortese, Ji-Young Lee, Berati Cerikan, Christopher J. Neufeldt, Viola M.J. Oorschot, Sebastian Köhrer, et al. (+23)
87 [GO] 2020―Nov―17 Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains Tongqing Zhou, Yaroslav Tsybovsky, Jason Gorman, Micah Rapp, Gabriele Cerutti, Gwo-Yu Chuang, et al. (+20)
88 [GO] 2020―Nov―13 Real-time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles Maolin Lu, Pradeep D. Uchil, Wenwei Li, Desheng Zheng, Daniel S. Terry, Jason Gorman, et al. (+17)
89 [GO] 2020―Oct―07 Mining the Antibody Repertoire for Solutions to SARS-CoV-2 Wenzhao Meng, Aaron M. Rosenfeld, Eline T. Luning Prak
90 [GO] 2020―Oct―01 ACTIVating Resources for the COVID-19 Pandemic: In vivo Models for Vaccines and Therapeutics Judith A. Hewitt, Cathleen Lutz, William C. Florence, M. Louise M. Pitt, Srinivas Rao, Jay Rappaport, Nancy L. Haigwood
91 [GO] 2020―Oct―01 Accelerated preclinical paths to support rapid development of COVID-19 therapeutics Jay A. Grobler, Annaliesa S. Anderson, Prabhavathi Fernandes, Michael S. Diamond, Christine M. Colvis, Joseph P. Menetski, et al. (+3)
92 [GO] 2020―Sep―09 Snatching the Crown from SARS-CoV-2 Lynda Coughlan
93 [GO] 2020―Sep―09 Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen M.E. Duyvesteyn, Helen M. Ginn, et al. (+19)
94 [GO] 2020―Sep―03 Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2 Sandra C.A. Nielsen, Fan Yang, Katherine J.L. Jackson, Ramona A. Hoh, Katharina Röltgen, Grace H. Jean, et al. (+19)
95 [GO] 2020―Aug―24 Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, et al. (+10)
96 [GO] 2020―Aug―10 Approaches and Challenges in SARS-CoV-2 Vaccine Development Gabriel Dagotto, Jingyou Yu, Dan H. Barouch
97 [GO] 2020―Jul―30 Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice James Brett Case, Paul W. Rothlauf, Rita E. Chen, Natasha M. Kafai, Julie M. Fox, Brittany Smith, et al. (+13)
98 [GO] 2020―Jul―18 Retrospective Multicenter Cohort Study Shows that Early Interferon Therapy is Associated with Favorable Clinical Responses in COVID-19 Patients Nan Wang, Yan Zhan, Linyu Zhu, Zhibing Hou, Feng Liu, Pinhong Song, et al. (+14)
99 [GO] 2020―Jul―03 Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2. James Brett Case, Paul W. Rothlauf, Rita E. Chen, Zhuoming Liu, Haiyan Zhao, Arthur S. Kim, et al. (+19)
100 [GO] 2020―Jul―03 A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition M. Eugenia Dieterle, Denise Haslwanter, Robert H. Bortz, Ariel S. Wirchnianski, Gorka Lasso, Olivia Vergnolle, et al. (+17)
101 [GO] 2020―Jun―19 Neutralisation of SARS-CoV-2 by destruction of the prefusion Spike Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen ME. Duyvesteyn, Helen M. Ginn, et al. (+19)
102 [GO] 2020―May―27 Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19 Annsea Park, Akiko Iwasaki
103 [GO] 2020―May―27 A Mouse Model of SARS-CoV-2 Infection and Pathogenesis Shi-Hui Sun, Qi Chen, Hong-Jing Gu, Guan Yang, Yan-Xiao Wang, Xing-Yao Huang, et al. (+17)
104 [GO] 2020―May―20 The innate immune system: fighting on the front lines or fanning the flames of COVID-19? Julia L. McKechnie, Catherine A. Blish
105 [GO] 2020―May―14 FAVORABLE ANAKINRA RESPONSES IN SEVERE COVID-19 PATIENTS WITH SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS George Dimopoulos, Quirijn de Mast, Nikolaos Markou, Maria Theodorakopoulou, Apostolos Komnos, Maria Mouktaroudi, et al. (+7)
106 [GO] 2020―May―14 Identification of Human Single-Domain Antibodies against SARS-CoV-2 Yanling Wu, Cheng Li, Shuai Xia, Xiaolong Tian, Yu Kong, Zhi Wang, et al. (+8)
107 [GO] 2020―May―13 Rational Vaccine Design in the Time of COVID-19 Dennis R. Burton, Laura M. Walker
108 [GO] 2020―May―13 SARS-CoV-2: A New Song Recalls an Old Melody Kanta Subbarao
109 [GO] 2020―May―13 The Challenges of Vaccine Development against a New Virus during a Pandemic Michael S. Diamond, Theodore C. Pierson
110 [GO] 2020―May―04 Heightened innate immune responses in the respiratory tract of COVID-19 patients Zhuo Zhou, Lili Ren, Li Zhang, Jiaxin Zhong, Yan Xiao, Zhilong Jia, et al. (+20)
111 [GO] 2020―Apr―30 A Dynamic Immune Response Shapes COVID-19 Progression Eugenia Ziying Ong, Yvonne Fu Zi Chan, Wan Ying Leong, Natalie Mei Ying Lee, Shirin Kalimuddin, Salahudeen Mohamed Haja Mohideen, et al. (+5)
112 [GO] 2020―Apr―21 Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure Evangelos J. Giamarellos-Bourboulis, Mihai G. Netea, Nikoletta Rovina, Karolina Akinosoglou, Anastasia Antoniadou, Nikolaos Antonakos, et al. (+22)
113 [GO] 2020―Apr―13 An Infectious cDNA Clone of SARS-CoV-2 Xuping Xie, Antonio Muruato, Kumari G. Lokugamage, Krishna Narayanan, Xianwen Zhang, Jing Zou, et al. (+10)
114 [GO] 2020―Apr―06 Infection and Rapid Transmission of SARS-CoV-2 in Ferrets Young-Il Kim, Seong-Gyu Kim, Se-Mi Kim, Eun-Ha Kim, Su-Jin Park, Kwang-Min Yu, et al. (+19)
115 [GO] 2020―Mar―16 A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 Alba Grifoni, John Sidney, Yun Zhang, Richard H. Scheuermann, Bjoern Peters, Alessandro Sette
116 [GO] 2020―Feb―07 Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China Aiping Wu, Yousong Peng, Baoying Huang, Xiao Ding, Xianyue Wang, Peihua Niu, et al. (+10)
 [1] 

116 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec